4.5 Article

Chlamydia suis and Chlamydia trachomatis induce multifunctional CD4 T cells in pigs

期刊

VACCINE
卷 35, 期 1, 页码 91-100

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2016.11.050

关键词

Chlamydia suis; Chlamydia trachomatis; Animal model; Swine; Vaccine development; One Health

资金

  1. Saskatchewan Health Research Foundation (SHRF)
  2. SHRF

向作者/读者索取更多资源

Chlamydia trachomatis infections are the most prominent bacterial sexually-transmitted disease worldwide and a lot of effort is put into the development of an effective vaccine. Pigs have been shown to be a valuable animal model for C trachomatis vaccine development. The aim of this study was to decipher the T-cell-mediated immune response to chlamydial infections including C. trachomatis and C suis, the chlamydia species naturally infecting pigs with a demonstrated zoonotic potential. Vaginal infection of pigs with C suis and C. trachomatis lasted from 3 to 21 days and intra-uterine infection was still present after 21 days in 3 out of 5 C suis- and 4 out of 5 C. trachomatis-inoculated animals and caused severe pathological changes. Humoral immune responses including neutralizing antibodies were found predominantly in response to C. suis starting at 14 days post inoculation. The T-cell-mediated immune responses to C. trachomatis and C suis-infections started at 7 days post inoculation and consisted mainly of CD4` T cells which were either IFN-gamma single cytokine-producing or IFN-gamma/TNF-alpha double cytokine-producing T-helper 1 cells. IL-17-producing CD4(+) T cells were rare or completely absent. The T-cell-mediated immune responses were triggered by both homologous or heterologous re-stimulation indicating that cross protection between the two chlamydia species is possible. Thus, having access to a working genital C suis and C. trachomatis infection model, efficient monitoring of the host-pathogen interactions, and being able to accurately assess the responses to infection makes the pig an excellent animal model for vaccine development which also could bridge the gap to the clinical phase for C trachomatis vaccine research. (C) 2016 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据